Author

E. M. Carmona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. H. Limper· 1 shared A. Limper· 1 shared J. E. Yi· 1 shared K. Schaefbauer· 1 shared T. J. Kottom· 1 shared T. Kottom· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 7 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. H. Limper

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gene Expression in Lung Epithelial Cells Following Interaction with Pneumocystis carinii and its Specific Life Forms Yields Insights into Host Gene Responses to Infection

T. J. Kottom, E. M. Carmona, A. H. Limper

The paper examines gene expression changes in lung epithelial cells after interaction with Pneumocystis carinii life forms, identifying cytokine, apoptotic, and anti-apoptotic gene responses.

bioRxiv · Nov 22, 2021Microbiology

Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9

T. Kottom, K. Schaefbauer, E. M. Carmona, J. E. Yi, A. Limper

This study evaluates the safety and toxicology of BRD5529, a CARD9 inhibitor, in mice, finding no significant adverse effects at tested doses.

bioRxiv · Nov 19, 2021Pharmacology & Toxicology